Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2024 Nov 13;35(6):361-369.
doi: 10.1515/jbcpp-2024-0118. eCollection 2024 Nov 1.

Choroidal and retinal alteration after long-term use of tadalafil: a prospective non-randomized clinical trial

Luca D'Andrea  1 , Gianluigi Califano  1 , Marco Abate  1 , Marco Capece  1 , Claudia Collà Ruvolo  1 , Felice Crocetto  1 , Maria Laura Passaro  1 , Gilda Cennamo  2 , Ciro Costagliola  1
Affiliations
Clinical Trial

Choroidal and retinal alteration after long-term use of tadalafil: a prospective non-randomized clinical trial

Luca D'Andrea et al. J Basic Clin Physiol Pharmacol. .

Abstract

Objectives: The purpose of this study is to investigate choroidal and retinal vascular features in patients taking PDE5is by measuring dynamic vascular alterations and neurostructural features of the retina before and after oral tadalafil administration.

Methods: The current clinical research involved 22 patients treated with tadalafil 20 mg on alternate days (OAD) after nerve-sparing robotic radical prostatectomy (NS-RARP) for prostate cancer. Patients underwent SD-OCT to assess ganglion cell complex (GCC), retinal nerve fiber layer (RNFL), and subfoveal choroidal thickness (SFCT), as well as OCTA to assess superficial capillary plexus (SCP), deep capillary plexus (DCP), choriocapillaris (CC), foveal avascular zone (FAZ), and radial peripapillary capillary thickness (RPC). All patients were evaluated at baseline (t0), and 3 (t1) and 6 (t2) months after the use of oral tadalafil.

Results: A statistically significant reduction in DCP and CC vessel density was found at t2 compared to baseline. According to the SFCT parameter, a statistically significant increase was observed from t0 to t1, and from t1 to t2. GCC parameter increased at t2 compared to baseline in a statistically significant way. No statistically significant differences were recorded between t0, t1 and t2 for the SCP, RPC, FAZ area, RNFL parameter.

Conclusions: Retinal and optic disc toxicity may be detected using modifications of capillary vessel density. Further studies are needed to detect the possible progression or regression of ocular or systemic vascular complications in long-term follow-up.

Keywords: OCTA; erectile dysfunction; radical prostatectomy; retinal vascularity; tadalafil.

PubMed Disclaimer

References

    1. Cappelleri, JC, Tseng, LJ, Stecher, V, Goldstein, I. Enriching the interpretation of the erectile dysfunction inventory of treatment satisfaction: characterizing success in treatment satisfaction. J Sex Med 2018;15:732–40. https://doi.org/10.1016/j.jsxm.2018.03.078 . - DOI - PubMed
    1. Vlachopoulos, C, Ioakeimidis, N, Aznaouridis, K, Terentes-Printzios, D, Rokkas, K, Aggelis, A, et al.. Prediction of cardiovascular events with aortic stiffness in patients with erectile dysfunction. Hypertension 2014;64:672–8. https://doi.org/10.1161/HYPERTENSIONAHA.114.03369 . - DOI - PubMed
    1. Moschos, MM, Nitoda, E. Pathophysiology of visual disorders induced by phosphodiesterase inhibitors in the treatment of erectile dysfunction. Drug Des Dev Ther 2016;8:3407–13. https://doi.org/10.2147/DDDT.S118015 . - DOI - PubMed - PMC
    1. Diederen, RM, La Heij, EC, Markerink-van Ittersum, M, Kijlstra, A, Hendrikse, F, de Vente, J. Selective blockade of phosphodiesterase types 2, 5 and 9 results in cyclic 3’5’ guanosine monophosphate accumulation in retinal pigment epithelium cells. Br J Ophthalmol 2007;91:379–84. https://doi.org/10.1136/bjo.2006.100628 . - DOI - PubMed - PMC
    1. Marmor, MF, Kessler, R. Sildenafil (viagra) and ophthalmology. Surv Ophthalmol 1999;44:153–62. https://doi.org/10.1016/s0039-6257(99)00079-x . - DOI - PubMed

Publication types

MeSH terms

LinkOut - more resources